FDA-approved for diabetes (Ozempic), obesity (Wegovy), and CV risk reduction with 7+ years of clinical and post-marketing data
The argument is that peptides encourage the body to carry out processes it already has pathways for such as secreting growth hormone, regulating cortisol, or improving circulation rather than introducing entirely foreign chemistry
Additionally, high-fat diet-induced lipid biosynthesis enzyme induction, including , , and , is more pronounced in the livers of Nrf2 / mice [76]
Monitoring Bone Health During Ozempic Treatment Whilst routine bone density monitoring is not required for all patients commencing Ozempic, a risk-stratified approach to skeletal health assessment is prudent, particularly for individuals with additional risk factors for osteoporosis or fractures
NHS and SPS guidance discourages multi-dose vial use outside of specific, policy-governed circumstances